Digest Network Come funziona
Network
/
Società
Ev
Non verificato

Evaxion Biotech

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaMedicina Salute BenesserePubblicità/Marketing/Media/Comunicazione

31 comunicati stampa

Guarda tutti i comunicati
01/07/2025
Biotecnologia
Annunci Economici
Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
25/06/2025
Biotecnologia
Annunci Economici
Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
03/06/2025
Biotecnologia
Annunci Economici
Evaxion receives grant funding to design new polio vaccine
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
27/05/2025
Biotecnologia
Annunci Economici
Evaxion announces business update and first quarter 2025 financial results
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
23/05/2025
Biotecnologia
Annunci Economici
Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
22/05/2025
Biotecnologia
Annunci Economici
Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
28/04/2025
Biotecnologia
Annunci Economici
80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
10/04/2025
Biotecnologia
Annunci Economici
Evaxion to present at World Vaccine Congress
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
01/04/2025
Biotecnologia
Finanza
Annunci Economici
Evaxion announces business update and full year 2024 financial results
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0
27/03/2025
Biotecnologia
Annunci Economici
Evaxion to announce business update and full year 2024 financial results on April 1, 2025
Fonte
Evaxion Biotech
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0